
Itamar Medical Ltd. Net Debt 2011-2026 | ITMR
Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]
Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.
Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.
Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.
Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.
Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.
Annual Net Debt Itamar Medical Ltd.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -2.3 M | -15.1 M | -1.47 M | 3.05 M | -5.57 M | -18.1 M | 5.15 M | 7.99 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.99 M | -18.1 M | -3.3 M |
References
- Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.
Net Debt of other stocks in the Medical devices industry
| Issuer | Net Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioSig Technologies
BSGM
|
252 K | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
38.7 M | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
-230 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-32.4 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
14.2 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
-3.31 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
6.46 M | - | -5.86 % | $ 30.6 M | ||
|
Second Sight Medical Products
EYES
|
961 K | - | -0.97 % | $ 54.4 M | ||
|
Insulet Corporation
PODD
|
468 M | $ 215.63 | -4.38 % | $ 15.2 B | ||
|
Profound Medical Corp.
PROF
|
-7.36 M | $ 5.78 | 12.23 % | $ 180 M | ||
|
Conformis
CFMS
|
-26.2 M | - | - | $ 16.4 M | ||
|
Quanterix Corporation
QTRX
|
7.4 M | $ 3.92 | 2.62 % | $ 167 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
529 M | $ 9.54 | - | $ 735 M | ||
|
AVITA Medical
RCEL
|
29.1 M | $ 3.97 | 3.39 % | $ 111 M | ||
|
Cardiovascular Systems
CSII
|
-64.6 M | - | 0.15 % | $ 844 M | ||
|
IRIDEX Corporation
IRIX
|
-4.29 M | $ 1.33 | -1.48 % | $ 21.5 M | ||
|
Apollo Endosurgery
APEN
|
-22.5 M | - | - | $ 475 M | ||
|
Avinger
AVGR
|
-16.3 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
230 M | - | -4.14 % | $ 702 M | ||
|
Sintx Technologies
SINT
|
-898 K | $ 2.55 | -0.77 % | $ 7.07 M | ||
|
CONMED Corporation
CNMD
|
802 M | $ 36.9 | 0.86 % | $ 1.15 B | ||
|
Smith & Nephew plc
SNN
|
1.5 B | $ 32.43 | 0.82 % | $ 23.8 B | ||
|
Soliton, Inc.
SOLY
|
-31.6 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
-9.02 K | - | -1.98 % | $ 98.3 M | ||
|
NanoVibronix
NAOV
|
-636 K | - | - | $ 1.08 M | ||
|
Electromed
ELMD
|
-10.5 M | $ 24.73 | 0.12 % | $ 209 M | ||
|
Sensus Healthcare
SRTS
|
-21.6 M | $ 4.21 | 6.31 % | $ 68.7 M | ||
|
Misonix, Inc.
MSON
|
5.72 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-4.95 M | - | - | $ 111 M | ||
|
Tactile Systems Technology
TCMD
|
-75.4 M | $ 26.86 | -0.02 % | $ 614 M | ||
|
TELA Bio
TELA
|
-5.65 M | $ 0.7 | -7.88 % | $ 16 M | ||
|
Intersect ENT, Inc.
XENT
|
50.8 M | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
11.2 M | $ 0.67 | -3.33 % | $ 36.5 M | ||
|
Aethlon Medical
AEMD
|
-4.85 M | $ 2.38 | 10.12 % | $ 3.71 M | ||
|
BIOLASE
BIOL
|
6.1 M | - | -13.19 % | $ 166 K | ||
|
Tandem Diabetes Care
TNDM
|
239 M | $ 24.02 | -2.02 % | $ 1.63 B | ||
|
InspireMD
NSPR
|
-5.65 M | $ 1.76 | -0.56 % | $ 113 M | ||
|
AdaptHealth Corp.
AHCO
|
1.64 B | $ 11.33 | -1.31 % | $ 1.53 B | ||
|
Penumbra
PEN
|
-152 M | $ 336.05 | 0.54 % | $ 13.1 B | ||
|
Myomo
MYO
|
-4.79 M | $ 0.69 | -0.33 % | $ 28.9 M | ||
|
Invacare Corporation
IVC
|
299 M | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
-22.8 M | $ 3.7 | -5.37 % | $ 138 M | ||
|
OrthoPediatrics Corp.
KIDS
|
83.3 M | $ 16.22 | 1.95 % | $ 381 M | ||
|
Outset Medical
OM
|
63 M | $ 3.49 | -1.27 % | $ 53.1 K | ||
|
Inspire Medical Systems
INSP
|
-433 M | $ 51.29 | -1.52 % | $ 1.51 B | ||
|
Pulmonx Corporation
LUNG
|
-31.6 M | $ 1.29 | -1.53 % | $ 52.5 M |